v3.26.1
Share Capital (Tables)
6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Schedule of the effect of share-based compensation on the statements of operations
    Six Months ended     Three Months ended     Six Months ended     Three Months ended  
    June 30,     June 30,     June 30,     June 30,  
    2026     2026     2025     2025  
    USD thousands     USD thousands     USD thousands     USD thousands  
Research and development     79       37       22       (39 )
General and administrative     142       50       223       118  
                                 
Total share-based compensation expenses     221       87       245       79  
Schedule of number and weighted average exercise prices of option
   

Weighted

average

exercise price

   

Number

of options

   

Weighted

average

remaining contractual

life (in years)

 
   

June 30, 2026 

   

June 30, 2026 

   

June 30, 2026 

 
Outstanding at January 1, 2026     0.14       31,492,720       6.71  
Forfeited     0.17       (1,418,880 )        
Granted     0.03       1,930,960       9.79  
                         
Outstanding at June 30, 2026     0.13       32,004,800       6.14  
Schedule of Unvested RSA
    Number of RSAs  
RSA   June 30, 2026  
Unvested at beginning of the year     10,071,360  
Granted     -  
Issuance of ordinary shares upon vesting of RSAs     (1,486,480 )
Forfeited     -  
         
Outstanding at June 30, 2026     8,584,880